Virax Biolabs Group Ltd (VRAX)

CIK 1885827 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Virax Biolabs Group Ltd.

Recent SEC filings

FiledFormAccession number
Sep 10, 2026424B30001193125-26-386697
Sep 4, 20266-K0001193125-26-383683
Sep 4, 2026424B50001193125-26-383658
Sep 3, 2026EFFECT9999999995-26-002878
Sep 2, 2026F-3/A0001193125-26-380474
Aug 26, 20266-K0001193125-26-368710
Aug 18, 20266-K0001193125-26-354722
Jul 31, 20266-K0001193125-26-326851
Jul 24, 2026F-30001193125-26-316130
Jul 16, 20266-K0001193125-26-305400
Jul 10, 20266-K0001193125-26-300880
Jul 9, 20266-K0001193125-26-299132
Jul 6, 202620-F0001193125-26-295158
Jun 24, 20266-K0001193125-26-281196
Jun 12, 20266-K0001193125-26-268604
May 26, 20266-K0001193125-26-237882
May 22, 20266-K0001193125-26-236980
May 15, 2026SCHEDULE 13G/A0001172661-26-002143
Apr 14, 20266-K0001193125-26-153963
Apr 10, 20266-K0001193125-26-151292
Mar 31, 202630001193125-26-134281
Mar 20, 202630000950130-26-000117
Mar 18, 202630001193125-26-113915
Mar 18, 20266-K0001193125-26-114283
Mar 18, 202630001193125-26-113905